Edition:
India

People: Kazia Therapeutics Ltd (KZIA.OQ)

KZIA.OQ on NASDAQ Stock Exchange Capital Market

5.12USD
23 May 2018
Change (% chg)

$-0.05 (-0.97%)
Prev Close
$5.17
Open
$5.12
Day's High
$5.12
Day's Low
$5.12
Volume
189
Avg. Vol
5,725
52-wk High
$6.64
52-wk Low
$2.28

Coffey, Steven 

Mr. Steven Roy Stent Coffey is Non-Executive Director of the Company. He is a chartered accountant, having spent his career in public practice since graduating from University of New South Wales in 1983. He has been a partner in the chartered accounting firm Watkins Coffey Martin since 1993. He is a registered company auditor and audits a number of large private companies as well as a number of not-for-profit entities. He has previously served on the board of an Australian listed public company. He is currently a board member of private family foundation.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --